Hasil Pencarian - Eric Lippert

Perbaiki Hasil
  1. 1
    A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology

    A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology oleh Simon Jaouen, Fanny Mingant, Brigitte Pan-Petesch, Eric Lippert, Emmanuelle Jeanpierre, Hubert Galinat

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

    Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms oleh Andréas Perrier-Cornet, Jean-Christophe Ianotto, Fanny Mingant, Maëla Perrot, Eric Lippert, Hubert Galinat

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor

    Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor oleh Fanny Mingant, Romain Didier, Martine Gilard, Françoise Martin, Pierre-Philippe Nicol, Valérie Ugo, Eric Lippert, Hubert Galinat

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocrit

    JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocrit oleh François Girodon, Eric Lippert, Pascal Mossuz, Irène Dobo, Nathalie Boiret-Dupré, Jean-François Lesesve, Sylvie Hermouet, Vincent Praloran

    Diterbitkan 2007-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Absence of CALR mutations in JAK2-negative polycythemia

    Absence of CALR mutations in JAK2-negative polycythemia oleh Aurélie Chauveau, Olivier Nibourel, Sylvie Tondeur, Damien Luque Paz, Olivier Mansier, Franciane Paul, Mathieu Wemeau, Claude Preudhomme, Eric Lippert, Valérie Ugo

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Low incidence of <i>EPOR</i> mutations in idiopathic erythrocytosis

    Low incidence of <i>EPOR</i> mutations in idiopathic erythrocytosis oleh Mathilde Filser, Bernard Aral, Fabrice Airaud, Aurélie Chauveau, Aisha Bruce, Yann Polfrit, Anne Thiebaut, Martin Gauthier, Cédric Le Maréchal, Eric Lippert, Stéphane Béziau, Céline Garrec, Betty Gardie, François Girodon

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms

    Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms oleh Marie Orliaguet, Sylvie Boisramé, Jean‐Richard Eveillard, Brigitte Pan‐Petesch, Marie‐Anne Couturier, Vincent Rebière, Gaelle Guillerm, Marie‐Caroline Le Bousse‐Kerdiles, Laurent Misery, Eric Lippert, Jean‐Christophe Ianotto

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation.

    Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation. oleh Aurélie Bedel, Jean-Max Pasquet, Eric Lippert, Miguel Taillepierre, Valérie Lagarde, Sandrine Dabernat, Pierre Dubus, Lucie Charaf, François Beliveau, Hubert de Verneuil, Emmanuel Richard, François-Xavier Mahon, François Moreau-Gaudry

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy

    Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy oleh Eric Lippert, Gabriel Etienne, Marie-Joelle Mozziconacci, Sophy Laibe, Carine Gervais, Stéphane Girault, Nathalie Gachard, Isabelle Tigaud, Nicole Dastugue, François Huguet, Marie-Pierre Fort, Laurence Legros, Virginie Eclache, Francois-Xavier Mahon

    Diterbitkan 2010-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Clinical and biological characterization of patients with low (0.1–2%) JAK2V617F allele burden at diagnosis

    Clinical and biological characterization of patients with low (0.1–2%) JAK2V617F allele burden at diagnosis oleh Eric Lippert, Olivier Mansier, Marina Migeon, Barbara Denys, Asa Nilsson, Carolina Rosmond, Laurence Lodé, Valérie Ugo, Axelle Lascaux, Beatriz Bellosillo, Joaquin Martinez-Lopez, Dina Naguib, Nathalie Gachard, Nicolas Maroc, Sylvie Hermouet

    Diterbitkan 2014-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

    Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy oleh Gabriel Etienne, Stéphanie Dulucq, Franck-Emmanuel Nicolini, Stéphane Morisset, Marie-Pierre Fort, Anna Schmitt, Madeleine Etienne, Sandrine Hayette, Eric Lippert, Caroline Bureau, Isabelle Tigaud, Didier Adiko, Gérald Marit, Josy Reiffers, François-Xavier Mahon

    Diterbitkan 2014-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

    Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or e... oleh Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms

    MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms oleh Pierre-Yves Dumas, Olivier Mansier, Valerie Prouzet-Mauleon, Junji Koya, Arnaud Villacreces, Philippe Brunet de la Grange, Damien Luque Paz, Audrey Bidet, Jean-Max Pasquet, Vincent Praloran, Franck Salin, Mineo Kurokawa, François-Xavier Mahon, Bruno Cardinaud, Eric Lippert

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22

    EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22 oleh An De Weer, Frank Speleman, Barbara Cauwelier, Nadine Van Roy, Nurten Yigit, Bruno Verhasselt, Barbara De Moerloose, Yves Benoit, Lucien Noens, Dominik Selleslag, Eric Lippert, Stephanie Struski, Christian Bastard, Anne De Paepe, Peter Vandenberghe, Anne Hagemeijer, Nicole Dastugue, Bruce Poppe

    Diterbitkan 2008-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    STAT1 activation in association with JAK2 exon 12 mutations

    STAT1 activation in association with JAK2 exon 12 mutations oleh Anna L. Godfrey, Edwin Chen, Charles E. Massie, Yvonne Silber, Francesca Pagano, Beatriz Bellosillo, Paola Guglielmelli, Claire N. Harrison, John T. Reilly, Frank Stegelmann, Fontanet Bijou, Eric Lippert, Jean-Michel Boiron, Konstanze Döhner, Alessandro M. Vannucchi, Carlos Besses, Anthony R. Green

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience

    Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience oleh Anne Sophie Alary, Carole Maute, Olivier Kosmider, Pierre Sujobert, Audrey Gauthier, Elizabeth Macintyre, Claude Preudhomme, Sandrine Hayette, Damien Luque-Paz, Fanny Baran-Marszak, Frederic Davi, Eric Lippert, Pascale Cornillet-Lefebvre, Marie Helene Delfau-Larue, Bruno Cassinat, Jean Michel Cayuela, Pascale Flandrin-Gresta

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis

    Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis oleh Sandrine Lemoine, Clelia Mornet, Isabelle Quintin-Roue, Marie-Christine Rousselet, Laurane Cottin, Aurélie Georgeais, Ludovic Dubouis, Françoise Boyer, Corentin Orvain, Clara Caillon, Maxime Renard, Valoris Le Brun, Lenaig Le Clech, Jean-Christophe Ianotto, Emmanuelle Génin, Barbara Burroni, Valérie Ugo, Damien Luque Paz, Eric Lippert

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study

    Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms... oleh Jean-Christophe Ianotto, Aurélie Chauveau, Françoise Boyer-Perrard, Emmanuel Gyan, Kamel Laribi, Pascale Cony-Makhoul, Jean-Loup Demory, Benoit de Renzis, Christine Dosquet, Jerome Rey, Lydia Roy, Brigitte Dupriez, Laurent Knoops, Laurence Legros, Mohamed Malou, Pascal Hutin, Dana Ranta, Omar Benbrahim, Valérie Ugo, Eric Lippert, Jean-Jacques Kiladjian

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

    JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes oleh Léa Sureau, Caroline Buors, Jean-Christophe Ianotto, Françoise Boyer, Aline Tanguy-Schmidt, Lydia Roy, Emilie Cayssials, Laura Cailly, Jean-Claude Chomel, Aurélie Chauveau, Corentin Orvain, Olivier Mansier, Dana Ranta, Margot Robles, Emmanuel Gyan, Olivier Hérault, Stanislas Nimubona, Tony Marchand, Eric Lippert, Jérémie Riou, Valérie Ugo, Damien Luque Paz

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

    Concordance of assays designed for the quantification of JAK2V617F: a multicenter study oleh Eric Lippert, François Girodon, Emma Hammond, Jaroslav Jelinek, N. Scott Reading, Boris Fehse, Katy Hanlon, Mirjam Hermans, Céline Richard, Sabina Swierczek, Valérie Ugo, Serge Carillo, Véronique Harrivel, Christophe Marzac, Daniela Pietra, Marta Sobas, Morgane Mounier, Marina Migeon, Sian Ellard, Nicolaus Kröger, Richard Herrmann, Josef T. Prchal, Radek C. Skoda, Sylvie Hermouet

    Diterbitkan 2009-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: